First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 18 05 2019
accepted: 08 07 2019
pubmed: 22 7 2019
medline: 15 1 2020
entrez: 22 7 2019
Statut: ppublish

Résumé

Clostridioides difficile has become the leading nosocomial Gram-positive pathogen in the developed countries. In Lithuania, the national surveillance program for C. difficile started in 2017. Enzyme immunoassay, the real-time PCR system, and culture are used for laboratory confirmation of C. difficile infection in Lithuanian clinical laboratories. No reference laboratory for C. difficile is present in Lithuania. Fifty-eight isolates of C. difficile were collected in 2016 and 2017 in two hospitals using real-time PCR and culture methods. Agarose gel-based PCR ribotyping, multilocus variable number tandem repeats analysis (MLVA), and multilocus sequence typing (MLST) were used for the genotypic characterization of 28 isolates. PCR ribotyping and MLST showed that 78.6% of the tested toxigenic isolates belong to the ribotype RT027/ST1. Using MLVA, 95.5% of RT027 isolates were genetically related. MLVA revealed three clonal complexes in RT027. Six non-RT027 isolates showed four different electrophoretic profiles in PCR ribotyping and were assigned to the MLST sequence types ST2, ST13, ST54, and ST63. The highest discriminatory power showed the genotyping by MLVA. In total, 20 MLVA profiles were identified. This genotyping technique allowed to identify four groups of RT027/ST1 isolates that were indistinguishable by PCR ribotyping and MLST. Our study is the first genotypic characterization of C. difficile isolates in Lithuania. We observed a high prevalence of presumptive RT027 that suggests unfavorable epidemiological situation in Lithuania. Our results stress for implementation of genotyping of C. difficile isolates in Lithuanian surveillance.

Identifiants

pubmed: 31327067
doi: 10.1007/s10096-019-03633-9
pii: 10.1007/s10096-019-03633-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1953-1959

Références

Mol Biol Evol. 1999 Sep;16(9):1125-34
pubmed: 10486968
J Med Microbiol. 2008 Nov;57(Pt 11):1377-82
pubmed: 18927415
Euro Surveill. 2013 Jan 24;18(4):20381
pubmed: 23369393
Euro Surveill. 2016 Jul 21;21(29):
pubmed: 27470194
Anaerobe. 2016 Aug;40:95-9
pubmed: 27370902
J Med Microbiol. 2011 Aug;60(Pt 8):1112-8
pubmed: 21393454
J Clin Microbiol. 2016 Mar;54(3):775-8
pubmed: 26699700
Clin Microbiol Infect. 2016 Aug;22 Suppl 4:S63-81
pubmed: 27460910
PLoS One. 2017 Aug 16;12(8):e0182307
pubmed: 28813461
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28137804
J Clin Microbiol. 2010 Mar;48(3):770-8
pubmed: 20042623
Front Microbiol. 2017 Jan 11;7:2138
pubmed: 28123380
Annu Rev Microbiol. 2017 Sep 8;71:281-307
pubmed: 28657883
Clin Microbiol Infect. 2018 May;24(5):469-475
pubmed: 29274463
Microb Pathog. 2016 Aug;97:59-78
pubmed: 27238460
Clin Microbiol Infect. 2018 Jul;24(7):682-683
pubmed: 29505883
Genome Biol Evol. 2018 Mar 1;10(3):982-998
pubmed: 29617810
Lancet. 2011 Jan 1;377(9759):63-73
pubmed: 21084111
J Clin Microbiol. 2007 Mar;45(3):1024-8
pubmed: 17166961
Sci Rep. 2018 Mar 5;8(1):3992
pubmed: 29507300
FEMS Microbiol Lett. 1999 Jun 15;175(2):261-6
pubmed: 10386377
Front Microbiol. 2018 Mar 27;9:566
pubmed: 29636739
BMC Microbiol. 2013 Jun 05;13:126
pubmed: 23738754
Infect Drug Resist. 2018 Apr 06;11:489-500
pubmed: 29670381
J Clin Microbiol. 2013 Dec;51(12):4141-9
pubmed: 24108611
Euro Surveill. 2016 Jul 21;21(29):
pubmed: 27469624
J Clin Microbiol. 2016 Jan;54(1):13-8
pubmed: 26511734
Infect Genet Evol. 2017 Apr;49:1-11
pubmed: 28012982
PLoS One. 2011;6(5):e19993
pubmed: 21625511

Auteurs

Simona Tratulyte (S)

Vilnius City Clinical Hospital, Vilnius, Lithuania.
Department of Microbiology and Biotechnology, Institute of Biosciences, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Jolanta Miciuleviciene (J)

Vilnius City Clinical Hospital, Vilnius, Lithuania.

Nomeda Kuisiene (N)

Department of Microbiology and Biotechnology, Institute of Biosciences, Life Sciences Center, Vilnius University, Vilnius, Lithuania. nomeda.kuisiene@gf.vu.lt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH